Veening-Griffioen, D. H., Ferreira, G. S., Boon, W., Gispen-de Wied, C. C., Schellekens, H., Moors, E., & Van Meer, P. (2021). Tradition, not science, is the basis of animal model selection in translational and applied research. ALTEX, 38(1), 49–62.
Greek, R., & Kramer, L. A. (2019). ” The Scientific Problems with Using Non-Human Animals to Predict Human Response to Drugs and Disease“. In Animal Experimentation: Working Towards a Paradigm Change. Leiden, The Netherlands: Brill.
Kramer, L.A. and Greek, R. (2018). Human Stakeholders and the Use of Animals in Drug Development. Business and Society Review, Vol. 123, Issue 1, pp. 3-58, 2018.
Pischon, H., Radbruch, M., Ostrowski, A., Schumacher, F., Hönzke, S., Kleuser, B., Hedtrich, S., Fluhr, J. W., Gruber, A. D., & Mundhenk, L. (2018). How Effective Is Tacrolimus in the Imiquimod-Induced Mouse Model of Psoriasis?. The Journal of investigative dermatology, 138(2), 455–458.
Seo, J., Shin, J. Y., Leijten, J., Jeon, O., Camci-Unal, G., Dikina, A. D., Brinegar, K., Ghaemmaghami, A. M., Alsberg, E., & Khademhosseini, A. (2018). High-throughput approaches for screening and analysis of cell behaviors. Biomaterials, 153, 85–101.
National Academies of Sciences, Engineering, and Medicine; Division on Earth and Life Studies; Board on Environmental Studies and Toxicology; Committee on Incorporating 21st Century Science into Risk-Based Evaluations (2017). Using 21st Century Science to Improve Risk-Related Evaluations. 6, Model and Assay Validation and Acceptance. Washington (DC): National Academies Press (US).
Casey W. M. (2016). Advances in the Development and Validation of Test Methods in the United States. Toxicological research, 32(1), 9–14.
Akhtar A. (2015). The flaws and human harms of animal experimentation. Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees, 24(4), 407–419.
Other scientific articles can be found at:
progressiveresearchsociety.com 